Prof. Dr. Bernd Neumaier
Academic Education and Prefessional Degrees
1992 | Diploma thesis: “Radiochemical determination of 7Be yields in the nuclear reaction 209Bi(p,7Be)203Hg up to 40 MeV”; Forschungszentrum Jülich GmbH |
1992 - 1996 | Dissertation: “Radiochemical studies on protein binding and affinity of Y(III)-complexes to bone metastases”; Forschungszentrum Jülich GmbH |
2009 | Habilitation and venia legendi in Nuclear Chemistry, Univ. Cologne |
Professional Career and Academic Achievements
1996 - 2006 | Head of Cyclotron/Radiopharmacy, University of Ulm |
2006 - 2013 | Head of Cyclotron/Radiopharmacy, Max-Planck-Institute for Neurological Research, Cologne |
2009 | Habilitation and venia legendi in Nuclear Chemistry, University of Cologne |
| Habilitation thesis: “Development of radiometal-labelled antibodies and nucleosides for endoradiotherapy of oncological diseases” |
2010 | Offer of a W3-Professorship for Radiopharmaceutical Chemistry, Ruprecht Karls University Heidelberg with German Research Cancer Center (DKFZ) (declined) |
2011 | Adjunct Professor, University of Cologne |
Since 2013 | Professor (W3) for Nuclear Chemistry and Director at the Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne |
Since 2015 | Professor (W3) for Nuclear Chemistry and Director of INM-5, Forschungszentrum Jülich GmbH |
Others (Editorships, Advisory Boards, Awards)
2009 - 2018 | Member of the Committee of the working group Radiochemistry/ Radiopharmacy (AGRR) of the German Society for Nuclear Medicine (DGN) |
2011 - 2018 | Member of the Board of Directors, German Society for Nuclear Medicine (DGN) |
2011 | Award winner of the innovative contest “365 Orte im Land der Ideen” for the project “Innovative imaging methods for the visualisation of stem cells in brain” |
Since 2015 | Member of the Radiopharmaceutical Working Group of the Pharmaceutical Chemistry Committee of the German Pharmacopoeia Commission |
2016 | SNMMI Image of the Year 2016 |
2017 - 2020 | Member of the Expert Group 14 (Radiopharmaceutical preparations) of the European Pharmacopoeia Commission |
Since 2019 | Member of the Board of Directors of the specialist group Nuclear Chemistry, German Chemical Society (GDCh) |
| Associate Editor of the Journal of Radioanalytical and Nuclear Chemistry (JRNC) |